Physician

Warren A Thompson, MD

According to 2025 Medicare claims, Warren Thompson, MD (NPI: 1962484790) practices ophthalmology in the Dothan, AL market, with the plurality of this provider's patient population coming from Houston, AL. This provider's primary affiliated billing organization is RETINA ASSOCIATES OF ALABAMA, INC (NPI: 1124042601; TIN: 20-2354132) and primary practice location at 36303-1996.

Thompson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,178 traditional Medicare patients, billed 66,183 HCPCS/CPT codes, and received $3,192,458 in Medicare payments. The top billing code was Q5128 (Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg). Part D data shows 1,056 prescription claims across 335 beneficiaries totaling $100,096 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 43 records totaling $879. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,404,505 to $3,192,458. Similarly, Part D prescription costs have risen steadily, from $74,729 to $100,096. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.6M$3.2M2015 Medicare payment: $1,404,505 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,808,120 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,627,130 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,646,901 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,848,055 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,746,033 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,321,922 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,871,345 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,812,018 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,192,458 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,65216,632$1,404,505
20161,78922,399$1,808,120
20171,68620,509$1,627,130
20181,62718,694$1,646,901
20191,62120,245$1,848,055
20201,41616,558$1,746,033
20211,96623,286$2,321,922
20221,26313,770$1,871,345
20231,24343,795$2,812,018
20241,17866,183$3,192,458

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$65K$129K2015 Drug cost: $74,729 (USD; Tot_Drug_Cst)2016 Drug cost: $83,985 (USD; Tot_Drug_Cst)2017 Drug cost: $94,942 (USD; Tot_Drug_Cst)2018 Drug cost: $93,316 (USD; Tot_Drug_Cst)2019 Drug cost: $94,062 (USD; Tot_Drug_Cst)2020 Drug cost: $111,025 (USD; Tot_Drug_Cst)2021 Drug cost: $129,162 (USD; Tot_Drug_Cst)2022 Drug cost: $125,090 (USD; Tot_Drug_Cst)2023 Drug cost: $114,514 (USD; Tot_Drug_Cst)2024 Drug cost: $100,096 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015244883$74,729
2016250801$83,985
2017275825$94,942
2018257767$93,316
2019266813$94,062
20203061,021$111,025
20213531,063$129,162
20223301,050$125,090
2023314986$114,514
20243351,056$100,096

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
Q5128Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg1814,104$177
67028Injection of drug into eye4661,959$86
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more692917$81
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5431,396$57
92134Imaging of retina1,0312,684$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine231,455$26,105
LumiganBimatoprost321,759$17,531
Prednisolone AcetatePrednisolone Acetate2088,447$11,342
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol512,366$8,002
TravoprostTravoprost311,591$4,689

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.43$879ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Warren A. Thompson, MD?

Tedicare shows public-source Medicare data for Warren A. Thompson, MD (NPI 1962484790), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Warren A. Thompson, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Warren A. Thompson, MD?

Warren A. Thompson, MD is linked to RETINA ASSOCIATES OF ALABAMA, INC (billing NPI 1124042601) in the available physician profile data.

Does Warren A. Thompson, MD have Open Payments data?

Warren A. Thompson, MD has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.